Recruitment procedure opens for next Executive Director of the European Medicines Agency

Draft guideline on quality aspects of mRNA vaccines for veterinary use

Draft guideline on quality aspects of mRNA vaccines for veterinary use

PSUSA/00001307/202507

Human medicines European public assessment report (EPAR): Palonosetron Accord, palonosetron, Date of authorisation: 26/05/2016, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Lyvdelzi (previously Seladelpar Gilead), seladelpar lysine dihydrate, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 22, Status: Authorised

Risk management requirements for elemental impurities in veterinary medicinal products - Scientific guideline

Human medicines European public assessment report (EPAR): Casgevy, exagamglogene autotemcel, Date of authorisation: 09/02/2024, Revision: 6, Status: Authorised